sanofi (SAN:EN Paris)
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
Dr. David-Alexandre Gros has been Senior Vice President and Chief Business Officer of Alnylam Pharmaceuticals, Inc. since June 8, 2015 and serves as its Member of Management Board. Dr. Gros served as the Chief Strategy Officer and Executive Vice President at Sanofi since September 1, 2011. Dr. Gros covers all Group business development and acquisition activities as well as strategic planning, economic evaluation of projects, strategic intelligence, and alliance management. ...
54, Rue La BoétiePhone: 33 1 53 77 40 00
Paris, Ile-de-France 75008
Fax: 33 1 53 77 42 96
Board Members Memberships*There is no Board Members Memberships data available.
Harvard Business School
Johns Hopkins School of Medicine
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Stanley T. Crooke M.D., Ph.D.||Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee|
Isis Pharmaceuticals, Inc.
|Edward M. Kaye M.D., Ph.D.||Interim Chief Executive Officer, Chief Medical Officer and Senior Vice President|
Sarepta Therapeutics, Inc.
|Mark W. Schwartz Ph.D.||Chief Executive Officer, President, Director and Member of Ad Hoc (Strategy, Pricing, Etc) Committee|
Galena Biopharma, Inc.
|Mark Joseph Murray Ph.D.||Chief Executive Officer, President and Director|
Arbutus Biopharma Corporation
|Paul C. Grint M.D.||Chief Executive Officer, President and Director|
Regulus Therapeutics Inc.
|--||Compensation as of Fiscal Year 2014.|